Renal failure during chemotherapy: Renal biopsy for assessing subacute nephrotoxicity of pemetrexed

Pemetrexed, a multitargeted antifolate cytotoxic agent, is currently used primarily in combination with cisplatin for metastatic non-small cell lung cancer and for malignant mesothelioma.